Skip to content

Author

Shu Xu

We have 2 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Combinatorial therapy with resveratrol sensitizes glioblastoma to NKG2D CAR-T cells

Preclinical findings identify RSV as a promising pharmacological adjuvant that enhances NKG2D CAR-T efficacy in glioblastoma, supporting further translational and clinical evaluation of this combinatory approach.

Wei Liang, Yexiao Tang, M. Saliu et al. · 0 citations
Jul 2026

Developing an epithelial signature for prognosis of papillary thyroid carcinoma.

Findings indicate that a malignant epithelial program defined by single-cell analysis can be translated into a four-gene signature associated with epithelial aggressiveness and TME remodeling in PTC, although its clinical utility requires validation in independent cohorts.

Zi-Yuan Wang, Shu Xu, Xuechen Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.